Evidence map›Paper›PMID 35352207›Full record

ArticleAmino acids2022

Lysine and homoarginine are closely interrelated metabolites in the rat.

Svetlana Baskal, Laurianne Dimina, Stefanos A Tsikas, Laurent Mosoni, Didier Remond, François Mariotti, Dimitrios Tsikas

Open access · hybridAbstract read
In one paragraph

Article in Amino acids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Svetlana Baskal *Institute of Toxicology, Core Unit Proteomics, Hannover Medical School, Carl-Neuberg-Str. 1, 30623, Hannover, Germany.
Laurianne Dimina *Université Paris-Saclay, AgroParisTech, INRAE, UMR PNCA, 75005, Paris, France.
Stefanos A TsikasAcademic Controlling, Hannover Medical School, 30623, Hannover, Germany.
Laurent MosoniUniversité Clermont Auvergne, INRAE, UNH, Clermont-Ferrand, France.
Didier RemondUniversité Clermont Auvergne, INRAE, UNH, Clermont-Ferrand, France.
François Mariotti *Université Paris-Saclay, AgroParisTech, INRAE, UMR PNCA, 75005, Paris, France.
Dimitrios Tsikas *Institute of Toxicology, Core Unit Proteomics, Hannover Medical School, Carl-Neuberg-Str. 1, 30623, Hannover, Germany. tsikas.dimitros@mh-hannover.de.ORCID http://orcid.org/0000-0001-6320-0956
Medizinische Hochschule Hannover · DEAgroParisTech · FRUniversité Clermont Auvergne · FR

Funding

French Research Agency (ANR) ANR-18-CE21-0001
6 · The paper itself

Abstract

L-Lysine (Lys) and L-arginine (Arg), but not L-homoarginine (hArg), are proteinogenic amino acids. In healthy humans, oral administration of hArg increased the plasma concentration of Lys, suggesting Lys as a metabolite of hArg. In humans and animals, hArg is biosynthesized from Arg and Lys by arginine:glycine amidinotransferase (AGAT). In vitro, recombinant human arginase and bovine liver arginase I hydrolyzed hArg to Lys, suggesting Lys as a metabolite of hArg. The aim of the present study was to investigate whether changes in blood concentrations of hArg and Lys in old rats fed for 4 months with varied controlled experimental diets could suggest interconversion of these amino acids. Blood samples (n = 253) were taken before (T0) and after 2 months (T2) and 4 months (T4) of the experiment. Plasma concentrations of Lys and hArg were determined by gas chromatography-mass spectrometry. The plasma hArg concentration markedly correlated with the plasma Lys concentration at all timepoints (r ≥ 0.7, P < 0.0001). Further analysis demonstrated that hArg and Lys are closely and specifically associated independently of experimental time/rat age and diet, suggesting that hArg and Lys are mutual metabolites in old rats. Based on the plasma concentration changes, the median yield of hArg from Lys was determined to be 0.17% at T0 and each 0.27% at T2 and T4. With a circulating concentration of about 3 µM, hArg a major metabolite of Lys in healthy humans. hArg supplementation is currently investigated as a cardioprotective means to improve impaired hArg synthesis. Present knowledge suggests that Lys rather than hArg supplementation may be even more favorable.

Indexed as

HomoarginineLysineAnimalsArginaseArginineCattleGas Chromatography-Mass SpectrometryRatsArginaseArginineHomoarginineLysineAGATArginaseGC–MSGuanidinoacetateL‐ArginineL‐HomoarginineL-LysineMetabolismPlasma

Identifiers

PMID35352207
PMCPMC9213308
OpenAlexW4220655612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.